CSI Market
Sign In | Register

Ensysce Biosciences Inc (ENSC) Annual Balance Sheets

Annual · GAAP · USD millions
Access ENSC quarterly Balance Sheets →
This page allows investors to track Ensysce Biosciences Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent4.31
Cash & Short-term Investments4.00
Unbilled Receivables, Current RE0.42
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.51
Total Current Assets7.24
Equipment/Property/Plant Net0.12
Other Assets, Noncurrent0.09
Operating Lease Right Of Use Current Asset-
Total Assets7.45
Liabilities
Accounts Payable, Current AC3.27
Other Accrued Liabilities, Current0.99
Notes Payable, Current NO0.31
Other Liabilities, Current0.00
Total Current Liabilities4.57
Long-term debt0.00
Other Long-term Debt, Noncurrent OT0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities4.57
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock142.93
Retained Earnings / Accumulated Deficit-139.72
Other Equity0.00
Common Stockholder's Equity3.21
Non-controlling interests & other-0.33
Total Stockholder's Equity2.88
Liabilities & Stockholder's Equity7.45
4 historic quarters locked

Sign in to unlock the full Ensysce Biosciences Inc balance sheet history.

Sign In Create Free Account

About Ensysce Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 30, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-013633

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.